Key Differences at a Glance Dosing Wegovy pill: Daily tablet on an empty stomach Injectable GLP-1s: Weekly self-injection Weight Loss Wegovy pill: ~1317% at 64 weeks Injectable GLP-1s: ~15%+ at 68 weeks Blood Sugar Impact Wegovy pill: Strong effect on insulin resistance with modest A1c reduction Injectables: Slightly greater A1c reductions overall Side Effects Wegovy pill: Similar GI effects (nausea, diarrhea)
Key Acupoints for GLP-1-Related Nausea: PC 6, ST 36, LI 4 By Woo Kyoung Lee, L.Ac., Ph.D., KMD The use of GLP-1 receptor agonists such as Wegovy, Ozempic, and Mounjaro has increased rapidly as patients seek effective treatment for weight loss and metabolic disorders
3D texture analyses within the substantia nigra of Parkinsons disease patients on quantitative susceptibility maps and R2* maps
Faber S, Fahrenholz T, Wolle MM, Kern JC, Pamuku M, Miller L, et al
Just like Ozempic or Wegovy (semaglutide), retatrutide is a glucagon-like peptide-1 (GLP-1) agonist